Replies to post #63170 on Biotech Values

[DewDiligence]

Re: IMM program in HCV

>The prototype compound belongs to an expanding class of compounds that has previously demonstrated activity against a related surrogate virus, bovine viral diarrhea virus (BVDV).<

This is the first I’ve heard of this approach to HCV drug discovery.